scholarly article | Q13442814 |
P50 | author | George Seage | Q90086356 |
Paige L Williams | Q92245374 | ||
Rohan Hazra | Q114429001 | ||
Ram Yogev | Q115624602 | ||
P2093 | author name string | Jennifer S Read | |
Raymond Griner | |||
Pediatric HIV/AIDS Cohort Study | |||
Kenneth Rich | |||
Marilyn Crain | |||
P2860 | cites work | Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission | Q33958839 |
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. | Q34158407 | ||
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. | Q34170220 | ||
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis | Q34992602 | ||
Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe | Q36193276 | ||
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children | Q36800856 | ||
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? | Q37491278 | ||
Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes | Q38450147 | ||
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies | Q41617111 | ||
Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. | Q43544846 | ||
Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). | Q43901906 | ||
Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008. | Q46456938 | ||
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children | Q80148569 | ||
P433 | issue | 7 | |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 385-394 | |
P577 | publication date | 2011-06-10 | |
P1433 | published in | AIDS Patient Care and STDs | Q15746602 |
P1476 | title | In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States | |
P478 | volume | 25 |
Q48258648 | A hierarchical modeling approach for assessing the safety of exposure to complex antiretroviral drug regimens during pregnancy |
Q36077016 | A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers |
Q36756151 | Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States |
Q35894019 | Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure |
Q92082821 | Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017 |
Q36438846 | Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design |
Q34881120 | Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers |
Q36547343 | Combination antiretroviral use and preterm birth |
Q34860149 | Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants |
Q41922010 | Darunavir for Use in Pregnant Women with HIV. |
Q36800100 | Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium |
Q37202019 | Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants |
Q38081072 | HIV protease inhibitors in pregnancy : pharmacology and clinical use. |
Q51365493 | In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana. |
Q28392255 | Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero |
Q54217059 | Is there a Higher Risk of Mother-to-Child Transmission of HIV Among Pregnant Women with Perinatal HIV Infection? |
Q37062155 | Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth |
Q35659264 | Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy |
Q33431825 | Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir |
Q36431061 | Maternal placental syndromes among women living with HIV in Ontario: a population-based study |
Q36951911 | Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure |
Q35622844 | Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications |
Q34440361 | Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age. |
Q37045192 | Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants |
Q37215994 | Safety of protease inhibitors in HIV-infected pregnant women |
Q34371989 | Safety of tenofovir during pregnancy for the mother and fetus: a systematic review |
Q26744617 | The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs |
Q57826130 | Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015 |
Q37587959 | Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007. |
Search more.